Postmarketing Cases of Enfortumab Vedotin-Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis

被引：23

作者：

Nguyen, Michelle Nadeau ^{[1
]}

Reyes, Melissa ^{[1
]}

Jones, S. Christopher ^{[1
]}

机构：

[1] US FDA, Div Pharmacovigilance, Off Surveillance & Epidemiol, Silver Spring, MD USA

来源：

JAMA DERMATOLOGY | 2021年 / 157卷 / 10期

关键词：

D O I：

10.1001/jamadermatol.2021.3450

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

This case series study uses data from the FDA Adverse Event Reporting System to investigate a potential association between enfortumab vedotin treatment and Stevens-Johnson Syndrome and toxic epidermal necrolysis.

引用

页码：1237 / 1239

页数：3

共 5 条

[1]

Astellas Pharma US., 2021, PADC PROD MON

[2] EPIDEMIOLOGY OF LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER IN THE US, EUROPE AND JAPAN [J].

Bharmal, M. ;

Guenther, S. ;

Kearney, M. ;

Kempel-Waibel, A. .

VALUE IN HEALTH, 2017, 20 (09) :A419-A419

[3]

Francis Andrea, 2021, JAAD Case Rep, V7, P57, DOI 10.1016/j.jdcr.2020.10.020

[4]

The Human Protein Atlas, 2015, TISS EXPR NECTIN 4

[5] Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction [J].

Viscuse, Paul V. ;

Marques-Piubelli, Mario L. ;

Heberton, Meghan M. ;

Parra, Edwin Roger ;

Shah, Amishi Y. ;

Siefker-Radtke, Arlene ;

Gao, Jianjun ;

Goswami, Sangeeta ;

Ivan, Doina ;

Curry, Jonathan L. ;

Campbell, Matthew T. .

FRONTIERS IN ONCOLOGY, 2021, 11

← 1 →